The presentation reiterates a 6-8% proforma revenue growth target for FY 2026 and a 22%-25% long-term Adjusted EBITDA margin corridor. Monitor upcoming quarterly filings for progress against these targets, particularly margin expansion from the ERP roll-off and Wound Care growth.
Price Chart
Executive Summary
InfuSystem filed an 8-K furnishing an investor presentation dated August 4, 2026. The presentation highlights FY 2025 net revenue of $143.4M (+6% YoY), Adjusted EBITDA of $31.5M (+25% YoY), and an LTM Adjusted EBITDA margin of 22.4% as of Q2 2026. The company guided for 6-8% proforma revenue growth in FY 2026 and a long-term Adjusted EBITDA margin target of 22%-25%, supported by the roll-off of a $2.6M ERP investment. The filing is a routine investor update with no new material financial disclosures beyond previously reported results and forward-looking targets.
Key Facts
- FY 2025 net revenue was $143.4M, up 6% YoY.
- FY 2025 Adjusted EBITDA was $31.5M, up 25% YoY.
- LTM Adjusted EBITDA margin as of Q2 2026 was 22.4%.
- FY 2026 proforma revenue growth guided at 6-8%.
- Long-term Adjusted EBITDA margin target is 22%-25%.
- A $2.6M ERP investment rolled off in 2025, expected to boost margins.
- Wound Care treatment revenue grew 103% YoY in 2025.
- Net leverage ratio was 0.61x with $55.2M in total available liquidity as of June 30, 2026.
- Operating cash flow (TTM) was $23.4M as of Q2 2026.
Financial Impact
FY 2025 net revenue $143.4M, Adjusted EBITDA $31.5M; FY 2026 guided 6-8% proforma revenue growth
Risk Factors
- Forward-looking statements are aspirational and subject to execution risk.
- Wound Care growth of 103% in 2025 may not be sustainable.
- Proforma revenue growth adjusts for a $7.1M prior-year contract restructuring, masking organic trends.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-052123 |
| Document: infu-20260804.htm | 0001628280-26-052123 |
| Document: 0001628280-26-052123-index-headers.html | 0001628280-26-052123 |
| Document: 0001628280-26-052123-index.html | 0001628280-26-052123 |
| Document: 0001628280-26-052123.txt | 0001628280-26-052123 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 11w ago | 8-K | $12.32 $12.46 | ▲ +1.14% | ▲ +1.24% | $13.81 (+12.09%) |
Aug 4, 2026 11w ago | 8-K | $12.32 $12.46 | ▲ +1.14% | ▲ +1.24% | $13.81 (+12.09%) |
Jul 28, 2026 12w ago | 8-K | $9.92 $9.22 | ▼ −7.06% | ▼ −9.33% | $13.81 (+39.21%) |
May 18, 2026 23w ago | 8-K | $9.67 $9.45 | ▼ −2.28% | ▼ −4.52% | $13.81 (+42.81%) |
May 14, 2026 23w ago | 8-K | $8.61 $9.94 | ▲ +15.45% | ▲ +16.16% | $13.81 (+60.39%) |
May 12, 2026 23w ago | 8-K | $8.21 $9.67 | ▲ +17.78% | ▲ +18.94% | $13.81 (+68.21%) |
May 8, 2026 24w ago | Insider Cluster | $8.41 $8.61 | ▲ +2.38% | ▲ +0.91% | $13.81 (+64.21%) |
May 8, 2026 24w ago | Insider Cluster | $8.41 $8.61 | ▲ +2.38% | ▲ +0.91% | $13.81 (+64.21%) |
May 7, 2026 24w ago | 8-K | $8.97 $8.21 | ▼ −8.47% | ▼ −9.98% | $13.81 (+53.96%) |
Apr 30, 2026 25w ago | 8-K | $10.13 $8.97 | ▼ −11.45% | ▼ −13.18% | $13.81 (+36.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers